Dec 15, 2021Patient Education: FAQMultiple Myeloma Research Foundation - MMRF - Multiple Myeloma Precursor Conditions Multiple Myeloma Precursor Conditions: Find out the difference between monoclonal gammopathy of undetermined significance (MGUS) and...
Jun 3, 2021Patient Education: FAQThe Binding Site: Introducing the iStopMM TrialThe Binding Site: Introducing the iStopMM Trial The Binding Site: Introducing the iStopMM Trial Learn more: The Binding Site...
Dec 19, 2020Patient Education: FAQMyeloma Canada: Patient Handbook - MGUS and Smoldering Multiple MyelomaMyeloma Canada: Patient Handbook - MGUS and Smoldering Multiple Myeloma https://myeloma.ca/pixms/uploads/serve/ckeditor/mgus_and_smm_info...
Dec 10, 2020Patient Education: FAQMGUS (Monoclonal gammopathy of undetermined significance) - > Smoldering Myeloma -> Multiple MyelomaMGUS (Monoclonal gammopathy of undetermined significance) - > Smoldering Myeloma -> Multiple Myeloma MGUS Diagnosis: Monoclonal...
Dec 1, 2020Patient Education: FAQThe 20/2/20 risk stratification model for Smoldering MyelomaOncologists use 20/2/20 model to calculate risk score to predict progression risk to active myeloma at 2 years for each individual...